2024-07-15 18:13:58
The Board of Directors of Techno Drugs Limited, a listed company in the pharmaceutical and chemical sector of the capital market, has released the unaudited financial report for the third quarter (January-March, 2024) and the nine-month quarter (July-March, 2023) of the current financial year. According to published reports, the company’s earnings per share (EPS) increased by 36 percent in the quarter under review.
On Monday (July 15), this information was revealed by Dhaka and Chittagong Stock Exchange (DSE-CSE) sources.
According to the data, the company’s earnings per share (EPS) for the 9 months of the current financial year has been Tk 2.58. The company’s EPS in the same period of the previous year was Rs.1.90. Accordingly, the profit of the company increased by Tk 0.68 or 36 percent in the current quarter.
Meanwhile, the company’s earnings per share (EPS) for the third quarter of the current financial year stood at Tk 0.42. In the same period last year, the company’s EPS was Rs.0.31. According to this, the profit of the company has increased by 0.11 taka or 35 percent in the current quarter.
As on March 31, 2024, the company’s NAV per share (NAVPS) stood at Tk 30.32.